InsidersTradesSigma
Follow the IMAGION BIOSYSTEMS LIMITED share price and the full insider trade history of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Market capitalisation: €6.4m. The latest transaction was reported on 25 August 2026 (Purchase). Among the most active insiders: Robert Romeo Proulx. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
IMAGION BIOSYSTEMS LIMITED is a company listed on the XASX, specializing in the development of medical imaging technologies. It focuses on innovative solutions for the early diagnosis of cancer.